|
 |
China Vaccine Market Report, 2007-2009
|
 
China is the largest vaccine producer and consumer in the world. According to the statistics of the General Administration of Customs, China's total vaccine import and export volume reached 34,846 tons in the first five months of 2008, of which 7,735 tons were imports, and 27,111 tons were exports. China's total vaccine import and export value in the same period was US$217.52 million, of which US$197.73 million was import value, and US$19.79 million was export value.
In 2007, China's total vaccine import and export volume reached 2,320 tons, of which 1,500 tons were imports, 820 tons were exports. China's total vaccine import and export value hit US$386.79 million, of which US$344.28 million was import value, and US$42.51 million was export value.
China Vaccine Import and Export, 2007
(unit: US$ million)
Source: China Customs; ResearchInChina
Based on the authoritative statistics of the National Bureau of Statistics, the State-Owned Assets Supervision and Administration Commission, the State Information Center, the Development Research Center of the State Council, the China Pharmaceutical Association, and the General Administration of Customs, this report makes in-depth analysis on China bio-pharmaceutical industry development, vaccine market, impact of SARS on vaccine market, vaccine import & export, key vaccine markets, key vaccine producers, investment opportunities and also makes forecast on the development trend of China's vaccine industry.
1. China Vaccine Market in Globalization Process
1.1 Impact of Globalization on China Pharmaceutical Market
1.1.1 Pharmaceutical Industry Restructuring and International Division of Labor
1.1.2 Accelerated Globalization Process of Pharmaceutical Market
1.1.3 International Status of China Pharmaceutical Industry
1.1.4 Forecast of China Status in Global Pharmaceutical Industry, 2009
1.2.1 China Vaccine Market
1.2.2 Policy on Foreign Capital Entry into China Vaccine Market
1.2.3 Competition Strategies of Chinese Vaccine Companies
1.3 China Vaccine Market Position in the Global Market
2. China Vaccine Market Development in 2008-2009
2.1 Market Characteristics, 2008
2.2 Main Vaccines Types, 2008
2.3 Market Structure, 2008
2.4 Market Characteristics, 2008
2.5 Market Development Trend, 2008
2.6 Suggestions for Vaccine Industry Development, 2008
3. Market of Main Varieties of Vaccine, 2008
3.1 China Flu Vaccine Market, 2008
3.1.1 Market Background
3.1.2 Research and Development
3.1.3 Market Size
3.1.4 Competition
3.1.5 Market Demand
3.1.6 Key Producers
3.2 China HBV Vaccine Market
3.2.1 Market Background
3.2.2 Market Size
3.2.3 Main Products
3.2.3.1 Plasma Derived HB Vaccine
3.2.3.2 Recombinant HB Vaccine
3.2.3.3 Recombinant Vaccine of HB Virus Surface Antigens（CHO cell）
3.2.3.4 New Type of HBV
3.2..4 Market Price
3.2.5 Key Producers
3.3 China Epidemic Cerebrospinal Meningitis Vaccine Market
3.3.1 Market Background
3.3.2 Market Size
3.3.2 Key Producers
3.4 China AIDS Vaccine Market
3.4.1 Market Background
3.4.2 Market Size
3.4.3 Research and Development
3.4.3.1 China Research on AIDS Vaccine
3.4.3.2 Research Direction
3.4.3.5 Process of Research Projects
3.5 China Bird Flu Vaccine Market
3.5.1. Market Background
3.5.2 Research and Development
3.5.3 Key Producers
3.6 Other Vaccine Market and Research and Development
3.6.1 Lung Cancer Vaccine
3.6.1.1 Tumor Cell Vaccine
3.6.1.2 Anti Tumor Antigen Vaccine
3.6.1.3 Anti-idiotypic Vaccine
3.6.1.4 DNA Vaccine
3.6.1.5 Dendritic Cell Vaccine
3.6.1.6 Peptide Vaccine
3.6.2 China Measles Vaccine Market
3.6.3 China Research on Cervical Cancer Vaccine
3.6.4 China Research on Lupus Erythematosus Vaccine
3.6.5 China Research on Rotavirus Vaccine
3.6.6 Principle of Tumor Vaccine
3.7 China Animal Vaccine Market
3.7.1 Development Advantages
3.7.1.1 Basis of Demand
3.7.1.2 Green Barriers: Promotion of Animal Vaccine
3.7.1.3 Market Background of and Demand for Pet Vaccine
3.7.1.4 Key Producers
3.7.2 Research Progress in Vaccine for Animal Use
3.7.2.1 Research and Development of Animal Virus Vaccine
3.7.2.2 R&D Bases of China Animal Vaccine
3.7.2.3 Successful Development of Purified Rabies Vaccine for Human Use
3.7.2.4 Research Progress in Pseudorabies Gene-deleted Vaccine
4. Impact of SARS on Vaccine Market
4.1 Vaccine Market Activated by SARS
4.1.1 Booming of Vaccine Industry
4.1.2 Bottleneck of Vaccine Industry
4.1.3 Research and Development of SARS Vaccine
4.2 Dispute of SARS Patent and Market
4.3 Patent Protection Measures on Anti SARS Vaccine
5. Import and Export of China Vaccine
5.1 General Trend of Vaccine Trade
5.3 Vaccine Export Regions Structure
5.4 Trade Methods Structure of Vaccine
5.5 Comparison between Imported Vaccine and Homemade Vaccine
6. China Key Vaccine Producers
6.1 Main Vaccine Companies
6.1.1 China National Biotech Group Co., Ltd
6.1.1.1 Company Profile
6.1.1.2 Operation Status
6.1.2 Beijing Tiantan Biological Products Co., Ltd.
6.1.2.1 Company Profile
6.1.2.2 Operation Status
6.1.3 Shanghai Institute of Biological Products
6.1.4 Shenzhen Kangtai Biological Products Co., Ltd
6.1.5 Changchun Changsheng Life Sciences Co., Ltd
6.1.6 Shenzhen Neptunus Bioengineering Co., Ltd
6.1.6.1 Company Profile
6.1.6.2 Operation Status
6.1.7 Guangxi Beisheng Pharmaceutical Co., Ltd.
6.1.7.1 Company Profile
6.1.7.2 Operation Status
6.1.8 Star Lake Bioscience Co., Ltd
6.1.8.1 Company Profile
6.1.8.2 Operation Status
6.1.9 Shanghai Fosun Pharmaceutical (Group) Co., Ltd
6.1.9.1 Company Profile
6.1.9.2 Operation Status
7. Vaccine Market Development Trend and Forecast, 2009
7.1 Latest Information on Vaccine Research and Development
7.1.1 Development Trend of New Type of Vaccine
7.1.2 New Types of Vaccines
7.1.2.1 Sub-unit Vaccine
7.1.2.2 Gene Recombination Vaccine
7.1.2.3 Synthetic Vaccine
7.1.2.4 Immunoglobulin Carrier Vaccine
7.1.3 Research and Development of New Type of Vaccine
7.1.3.1 Vaccine for Prevention of Respiratory Disease
7.1.3.2 Vaccine for Prevention of Digestive Disease
7.1.3.3 Vaccine for Prevention of Arbo Infectious Disease
7.1.4 New Type of Combined Vaccine
7.1.4.1 Development History
7.1.4.2 Applications and Problems of Combined Vaccine
7.1.4.3 Development of Combined Vaccine
7.1.4.4 Taking Oral Combined Vaccine
7.1.4.5 Immunity of Measles
7.1.4.6 Immunity of Mumps
7.1.4.7 Application of Varicella Vaccine
7.2 Forecast of Varicella Vaccine Market, 2009
8. Operation Status of Biopharmaceutical Industry
8.1 Operation Status, 2007
8.1.1 Output Value and Its Changes, 2007
8.1.2 Sales Revenue and Its Changes, 2007
8.1.3 Total Output Value and Its Changes, 2007
8.1.4 Changes in the Number of Key Producers, 2007
8.1.5 Profit and Its Changes, 2007
8.2 Business Operation of Top Ten Companies, 2007
8.2.1 Changes in Sales Revenue of Top Ten Companies, 2007
8.2.2 Changes in Assets of Top Ten Companies, 2007
8.2.3 Changes in Profit of Top Ten Companies, 2007
8.2.4 Changes in Employees of Top Ten Companies, 2007
Flu Vaccine Proportion in Main Vaccine Market
Flu Vaccine Producers Overseas
Flu Vaccine Producer at Home
China Key Vaccine Producers and Products
Virus Vaccine-Split Influenza Virus Vaccine's Dosage Form, Price & Origin, 2008
HB Vaccine Proportion in Main Vaccine Market
Virus Vaccine-Recombinant Vaccine of HB's (CHO cell）Dosage Form, Price & Origin, 2008
Virus Vaccine-Recombinant Vaccine of HB's (Barm) Dosage Form, Price & Origin, 2008
Main HB Vaccine Producers
Morbidity & Mortality of 27 kinds of Infectious Diseases Reported Statutorily
Main Regions of Epidemic Cerebrospinal Meningitis
Total Volume of Epidemic Cerebrospinal Meningitis Vaccine Put into Anhui Province and Jiangsu Province
Statistics of China HIV-infected Patients
Informed Rate of China HIV-infected Patients
Forecast of China Future AIDS Vaccine Market
Profit Margin of Bird Flue Vaccine
Comparison of Import Value between Anti-serum and Vaccine in 2007-2008
Comparison of Import Volume between Anti-serum and in 2007-2008
Anti-serum and Vaccine Export Value, 2007-2008
Anti-serum and Vaccine Export Volume, 2007-2008
Profitability of Beijing Tiantan Biological Products Co., 2007-2008
Operation Ability of Beijing Tiantan Biological Products Co., 2007-2008
Debt-paying Ability of Beijing Tiantan Biological Products Co., 2007-2008
Capital Structure of Beijing Tiantan Biological Products Co., 2007-2008
Development Ability of Beijing Tiantan Biological Products Co., 2007-2008
Cash Flow of Beijing Tiantan Biological Products Co., 2007-2008
Profitability of Shenzhen Neptunus Bioengineering Co., 2007-2008
Operation Ability of Shenzhen Neptunus Bioengineering Co.,2007-2008
Debt-paying Ability of Shenzhen Neptunus Bioengineering Co., 2007-2008
Capital Structure of Shenzhen Neptunus Bioengineering Co., 2007-2008
Development Ability of Shenzhen Neptunus Bioengineering Co., 2007-2008
Cash Flow of Beijing Shenzhen Neptunus Bioengineering Co., 2007-2008
Profitability of Guangxi Beisheng Pharmaceutical Co.,2007-2008
Operation Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
Debt-paying Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
Capital Structure of Guangxi Beisheng Pharmaceutical Co.,2007-2008
Development Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
Cash Flow of Beijing Guangxi Beisheng Pharmaceutical Co., 2007-2008
Profitability of Star Lake Bioscience Co., 2007-2008
Operation Ability of Star Lake Bioscience Co., 2007-2008
China Top 10 Pharmaceutical Giants, 2007
Hepatitis Vaccine Market Size Forecast, 2009
Vaccine for Children Market Forecast, 2009
Vaccine for Adults and Flu Vaccine Market Forecast,2009
Therapeutic Vaccine Market Size Forecast, 2009
China Pharmaceutical Industry Statistics, 2000-2009 Thanks to the stimulus of new medical system reform launched by the government in 2009, the pharmaceuticals industry of China remains steady growth.
In the first half of 2009, the output of China’s c... China Antibiotic Market Report, 2008-2009 From the perspective of industrial scale, China's output and production capacity of antibiotic raw materials ranks the NO.1 in the world. In 2007, China's sales revenue of antibiotic raw materials rea... China Pharmaceutical Chain Industry Report, 2009 According to the chain drug stores ranking in China in 2009, top 100 enterprises in China pharmaceutical chain industry achieved the sales revenue of RMB57.24 billion in 2008, increasing by RMB13.33 b... China Vaccine Industry Report, 2008-2009 In the past decade, Chinese vaccine market tripled in scale. China has already become the world’s largest vaccine producer and now has 28 vaccine companies, ranking NO.1 around the globe. It can produ... US Pharmaceutical Industry Report, 2008-2009 The United States has the largest pharmaceutical industry in the world. In 2007, its pharmaceutical revenue totaled at US$ 315 billion.
Global Pharmaceutical Output Value and Profits by Region, 2007... Indian Pharmaceutical Formulations Industry Report, 2008-2009 India plays an important role in the global pharmaceutical market. In 2005, 2/5 DMFs to FDA were submitted by India. Currently, there are more than 400 kinds of API (Active Pharmaceutical Ingredient) ... Indian Active Pharmaceutical Ingredients(APIs) Industry Report, 2008-2009 India plays an important part in the global API market. The API output value of India was US $4.1 billion in 2007, with the CAGR as high as 18.81% during 2003-2007. And Indian ranks at the fourth in t... China Chemical Pharmaceutical Market Report, 2008 By the end of Aug, 2008, the total output value of China’s chemical pharmaceutical industry was CNY 273.272 billion, among which, the total output value of active pharmaceutical ingredient (API) was C... China Vaccine Market Report, 2007-2009 China is the largest vaccine producer and consumer in the world. According to the statistics of the General Administration of Customs, China's total vaccine import and export volume reached 34,846 ton... China Pharmaceutical Chain Industry Report, 2007-2008 Pharmaceutical industry is called as "eternal sunrise industry", mainly because of its sustained growth in market demand. The main factors driving the growth in market demand of China's pharmaceutical... China Animal Vaccine Industry Report, 2006-2009 On Jan. 18th of 2008, Ministry of Agriculture of the People's Republic of China and Ministry of Health of China jointly issued the document to intensify the efforts to carry out the inoculation of rab... China Chemical Pharmaceutical Industry Report, 2007 Global medicine industry maintains rapid growth continuously.Its scale has started to maintain fast growth since the middle and late in the 20th century. The total output value increased to USD 602 bi... Company Study of Guangxi Wuzhou Zhongheng Group In 2006, the company received the main business revenue of RMB 321.1685 million, of which the pharmaceutical industry accounted for 62.83%; the profit of main business reached RMB 154.1201 million and... China OTC Drug Market Report, 2007 By 2003, the global OTC drug market had reached 63 billion, and China's OTC drugs shared 5.7% of the global market, only behind North America, West Europe and Japan. In 2003, the sales value in China'... China Pharmaceutical Industry Report, 2006-2007 In Jan-Feb 2007, Product sales revenue of China pharmaceutical industry rose by 17.8% year-on-year and, the gross profits increased by 29.6% from a year earlier.
It is noteworthy that the sales of ch... China Anti-tumor Drugs Market Report, 2007 The anti-tumor drugs market operated well in 2006, and the total sales volume amounted to USD 34.6 billion, up 20.5% from a year earlier, and the growth margin ranked the first place among all the tre... Economic Operation of Pharmaceutical Industry in China, 2006 In 2006, total industrial output value of China pharmaceutical industry accumulated to RMB532.373 billion, up by 17.89% year on year. Total industrial output value of state-owned economy of pharmaceut... China Pharmaceutical Industry Report (Merger and Reorganization), 2006-2007 During the Tenth Five-Year Plan period (2001 to 2005), each indicator of the whole pharmaceutical industry greatly exceeded the scheduled; and the industrial output value, industrial added value and t...
|